Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
VERENIUM Add to My Watchlist (NSDQ: VRNM) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Verenium 4.71 -0.07 (-1.46%) 113,682
55 Cambridge Parkway
Cambridge, MA 02142 US
(617) 674-5300
(858) 526-5551 fax
www.verenium.com
CEO Carlos A. Riva
Auditor Ernst & Young LLP
Exchange Traded NQ
ISIN Number US92340P2092
CIK Number 1049210
NAICS Code 541711
Business Summary
The company operates in two business segments, biofuels and specialty enzymes.
Number of Employees 303
Share Fundamentals
Market Cap 55.18M
Shares Outstanding 11.72M
Float 2.21M
Short Interest 437.30K
Financial Strength
Revenue (TTM) $69,037,000
Earnings (TTM) -$39,372,000
Quick Ratio 1:1
Current Ratio 1.2:1
Total Debt/Equity 0:1
Profitability
Gross Margin 76.5%
EBITDA Margin -86.0%
Profit Margin -94.0%
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Market News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs